Polydopamine-mediated EGCG-modified polystyrene microspheres for the synergistic removal of inflammatory cytokines TNF-α and bilirubin in liver failure
Regenerative Biomaterials · 22.01.2026 · 13
DOI: 10.1093/rb/rbag069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 10.04.2026. Verfasst von Yunzheng Du und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Science and Technology Program, National Key Research and Development Program of China.
Abstract (Originalsprache)
Hemoperfusion has emerged as a crucial treatment for liver failure in clinics. However, the challenge remains in the incapacity to effectively and concurrently eliminate multiple harmful toxins, including inflammatory cytokines and bilirubin. This study employed molecular docking for directing the design of adsorbents. To develop a multi-target adsorbent material for liver failure, capable of absorbing both bilirubin and tumor necrosis factor-α (TNF-α), a functional platform was constructed. This platform employs a TiO2-modified polystyrene-based microsphere PSVT, which was designed for bilirubin adsorption, and coated with polydopamine and grafted with epigallocatechin gallate (EGCG) for TNF-α adsorption. The results confirm that EGCG possesses a high binding affinity for TNF-α, and the introduction of EGCG as a functional moiety markedly improves the clearance effectiveness of TNF-α. Meanwhile, PSVT served as the foundation to guarantee the effective removal of bilirubin. PSVT/P/EGCG exhibits outstanding clearance performance, with a maximum adsorption capacity of 263 ng/g for TNF-α and 23.91 mg/g for bilirubin, demonstrating its high efficiency in removing both inflammatory mediators and toxins. EGCG contributes exceptional antioxidant capabilities to PSVT/P/EGCG. The adsorbent exhibits remarkable biocompatibility and stability. The multi-target adsorbent material developed in this study has an extensive spectrum of potential applications in liver failure treatment employing an artificial liver.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.
- General Hospital Tianjin Medical University, Tianjin 300052, China.
- Hubei Key Laboratory of Multi-media Pollution Cooperative Control in Yangtze Basin, School of Environmental Science & Engineering, Huazhong University of Science and Technology (HUST), Hubei, 430074, China.
Förderung
- National Natural Science Foundation of China
- Tianjin Science and Technology Program
- National Key Research and Development Program of China
Zitieren
APA
Du, Y., Liu, Z., Chai, Y., Wang, B., Wang, L., Wang, Z., Guo, X., Zhou, G., Yang, J., Zhu, C., Yang, L., Lv, X., & Ou, L. (2026). Polydopamine-mediated EGCG-modified polystyrene microspheres for the synergistic removal of inflammatory cytokines TNF-α and bilirubin in liver failure. Regenerative Biomaterials, 13. https://doi.org/10.1093/rb/rbag069
Vancouver
Du Y, Liu Z, Chai Y, Wang B, Wang L, Wang Z, et al. Polydopamine-mediated EGCG-modified polystyrene microspheres for the synergistic removal of inflammatory cytokines TNF-α and bilirubin in liver failure. Regenerative Biomaterials. 2026;13. doi:10.1093/rb/rbag069
BibTeX
@article{Du2026,
author = {Du, Yunzheng and Liu, Zhuang and Chai, Yamin and Wang, Biao and Wang, Lichun and Wang, Zimeng and Guo, Xiaofang and Zhou, Guanlun and Yang, Jingxuan and Zhu, Chunling and Yang, Leilei and Lv, Xinyao and Ou, Lailiang},
title = {Polydopamine-mediated EGCG-modified polystyrene microspheres for the synergistic removal of inflammatory cytokines TNF-α and bilirubin in liver failure},
journal = {Regenerative Biomaterials},
year = {2026},
volume = {13},
doi = {10.1093/rb/rbag069}
}
EUVIMED